Chemours Lifts FY18 Outlook

(RTTNews) - Chemours Co. (CC), Monday lifted its outlook for the full year, as it continues to see "robust demand" for its products.

Chemours, the chemical company that was spun off from DuPont in 2015, now expects adjusted earnings per share of $4.95 to $5.60 per share. Analysts polled by Thomson Reuters currently estimate earnings of $5.41 per share for the full year.

The company expects 2018 adjusted EBITDA at the high end of a previously announced range between $1.7 billion and $1.85 billion.

Chemours President and CEO Mark Vergnano said: "We ended 2017 with incredible momentum in all of our businesses and strong demand signals for both Fluoroproducts and Titanium Technologies. With nearly one quarter behind us, we continue to see robust demand for Ti-Pure™ titanium dioxide alongside a more favorable than expected demand and pricing backdrop for our Fluoroproducts segment."